Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2011 4
2012 1
2013 2
2014 1
2015 1
2016 1
2017 1
2018 3
2019 3
2020 3
2021 1
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia.
Cappellini MD, Viprakasit V, Taher AT, Georgiev P, Kuo KHM, Coates T, Voskaridou E, Liew HK, Pazgal-Kobrowski I, Forni GL, Perrotta S, Khelif A, Lal A, Kattamis A, Vlachaki E, Origa R, Aydinok Y, Bejaoui M, Ho PJ, Chew LP, Bee PC, Lim SM, Lu MY, Tantiworawit A, Ganeva P, Gercheva L, Shah F, Neufeld EJ, Thompson A, Laadem A, Shetty JK, Zou J, Zhang J, Miteva D, Zinger T, Linde PG, Sherman ML, Hermine O, Porter J, Piga A; BELIEVE Investigators. Cappellini MD, et al. N Engl J Med. 2020 Mar 26;382(13):1219-1231. doi: 10.1056/NEJMoa1910182. N Engl J Med. 2020. PMID: 32212518 Clinical Trial.
Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trial.
Taher AT, Cappellini MD, Kattamis A, Voskaridou E, Perrotta S, Piga AG, Filosa A, Porter JB, Coates TD, Forni GL, Thompson AA, Tartaglione I, Musallam KM, Backstrom JT, Esposito O, Giuseppi AC, Kuo WL, Miteva D, Lord-Bessen J, Yucel A, Zinger T, Shetty JK, Viprakasit V; BEYOND Investigators. Taher AT, et al. Lancet Haematol. 2022 Oct;9(10):e733-e744. doi: 10.1016/S2352-3026(22)00208-3. Epub 2022 Aug 22. Lancet Haematol. 2022. PMID: 36007538 Clinical Trial.
Effects of Germline VHL Deficiency on Growth, Metabolism, and Mitochondria.
Perrotta S, Roberti D, Bencivenga D, Corsetto P, O'Brien KA, Caiazza M, Stampone E, Allison L, Fleck RA, Scianguetta S, Tartaglione I, Robbins PA, Casale M, West JA, Franzini-Armstrong C, Griffin JL, Rizzo AM, Sinisi AA, Murray AJ, Borriello A, Formenti F, Della Ragione F. Perrotta S, et al. Among authors: scianguetta s. N Engl J Med. 2020 Feb 27;382(9):835-844. doi: 10.1056/NEJMoa1907362. N Engl J Med. 2020. PMID: 32101665
Iron overload enhances human mesenchymal stromal cell growth and hampers matrix calcification.
Borriello A, Caldarelli I, Speranza MC, Scianguetta S, Tramontano A, Bencivenga D, Stampone E, Negri A, Nobili B, Locatelli F, Perrotta S, Oliva A, Della Ragione F. Borriello A, et al. Among authors: scianguetta s. Biochim Biophys Acta. 2016 Jun;1860(6):1211-23. doi: 10.1016/j.bbagen.2016.01.025. Epub 2016 Feb 3. Biochim Biophys Acta. 2016. PMID: 26850692
LEOPARD syndrome: clinical dilemmas in differential diagnosis of RASopathies.
Santoro C, Pacileo G, Limongelli G, Scianguetta S, Giugliano T, Piluso G, Ragione FD, Cirillo M, Mirone G, Perrotta S. Santoro C, et al. Among authors: scianguetta s. BMC Med Genet. 2014 Apr 26;15:44. doi: 10.1186/1471-2350-15-44. BMC Med Genet. 2014. PMID: 24767283 Free PMC article.
Hereditary hypochromic microcytic anemia associated with loss-of-function DMT1 gene mutations and absence of liver iron overload.
Casale M, Borriello A, Scianguetta S, Roberti D, Caiazza M, Bencivenga D, Tartaglione I, Ladogana S, Maruzzi M, Della Ragione F, Perrotta S. Casale M, et al. Among authors: scianguetta s. Am J Hematol. 2018 Mar;93(3):E58-E60. doi: 10.1002/ajh.24988. Epub 2017 Dec 8. Am J Hematol. 2018. PMID: 29178181 Free article. No abstract available.
Long-term improvement in cardiac magnetic resonance in β-thalassemia major patients treated with deferasirox extends to patients with abnormal baseline cardiac function.
Casale M, Filosa A, Ragozzino A, Amendola G, Roberti D, Tartaglione I, De Michele E, Cozzolino D, Rispoli G, Palmieri F, Pugliese U, Scianguetta S, Signoriello G, Musallam KM, Perrotta S. Casale M, et al. Among authors: scianguetta s. Am J Hematol. 2019 Mar;94(3):312-318. doi: 10.1002/ajh.25370. Epub 2018 Dec 11. Am J Hematol. 2019. PMID: 30489651 Free article.
22 results